Diagnostic challenges for Pompe disease: An under-recognized cause of floppy baby syndrome
暂无分享,去创建一个
Barry Byrne | B. Byrne | R. Howell | M. Nicolino | B. Darras | P. Kishnani | Basil T Darras | R Rodney Howell | Marc Nicolino | Priya Kishnani | Ans van der Ploeg | A. T. Ploeg | Basil T. Darras | A. T. van der Ploeg | R. Howell
[1] A. Kahn,et al. Adenovirus-mediated transfer of the acid alpha-glucosidase gene into fibroblasts, myoblasts and myotubes from patients with glycogen storage disease type II leads to high level expression of enzyme and corrects glycogen accumulation. , 1998, Human molecular genetics.
[2] J. Charrow,et al. Recombinant human acid α-glucosidase enzyme therapy for infantile glycogen storage disease type II: Results of a phase I/II clinical trial , 2001, Genetics in Medicine.
[3] A. Reuser,et al. Enzyme therapy for Pompe disease: from science to industrial enterprise , 2007, European Journal of Pediatrics.
[4] A. Reuser,et al. Glycogenosis type II (acid maltase deficiency) , 1995, Muscle & nerve. Supplement.
[5] L. Sandkuijl,et al. Glycogen Storage Disease Type II: Birth Prevalence Agrees with Predicted Genotype Frequency , 2000, Public Health Genomics.
[6] M. Kroos,et al. Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counselling , 1999, European Journal of Human Genetics.
[7] I. Nishino. Autophagic vacuolar myopathies , 2003, Current neurology and neuroscience reports.
[8] C. Scriver,et al. The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.
[9] J. Smeitink,et al. Enzyme therapy for Pompe disease with recombinant human α-glucosidase from rabbit milk , 2001, Journal of Inherited Metabolic Disease.
[10] T. Choudhury,et al. Glycogen storage disease (type-III). , 1991, Indian pediatrics.
[11] W. Hop,et al. Long-Term Intravenous Treatment of Pompe Disease With Recombinant Human -Glucosidase From Milk , 2004 .
[12] W. Rom,et al. Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the disease. , 1998, American journal of medical genetics.
[13] W. Hop,et al. The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature. , 2003, Pediatrics.
[14] C. Prasad,et al. The floppy infant: contribution of genetic and metabolic disorders , 2003, Brain and Development.
[15] A. Ross,et al. Anaesthetic management of infants with glycogen storage disease type II: a physiological approach , 2004, Paediatric anaesthesia.
[16] Phillip D. K. Lee. Disease management of Prader–Willi syndrome , 2002, Expert opinion on pharmacotherapy.
[17] H. Jones,et al. Diagnosis of pediatric neuromuscular disorders in the era of DNA analysis. , 2000, Pediatric neurology.
[18] A. Reuser,et al. Recombinant human alpha-glucosidase from rabbit milk in Pompe patients. , 2000, Lancet.
[19] J. Metzl,et al. An Interesting Case of Infant Sudden Death: Severe Hypertrophic Cardiomyopathy in Pompe's Disease , 1999, Pacing and clinical electrophysiology : PACE.
[20] A. Vulto,et al. Recombinant human α-glucosidase from rabbit milk in Pompe patients , 2000, The Lancet.
[21] P. Meikle,et al. Determination of Acid α-Glucosidase Protein: Evaluation as a Screening Marker for Pompe Disease and Other Lysosomal Storage Disorders , 2000 .
[22] A. Haqq,et al. Effects of growth hormone on pulmonary function, sleep quality, behavior, cognition, growth velocity, body composition, and resting energy expenditure in Prader-Willi syndrome. , 2003, The Journal of clinical endocrinology and metabolism.
[23] M. Gelb,et al. Direct multiplex assay of lysosomal enzymes in dried blood spots for newborn screening. , 2004, Clinical chemistry.
[24] C. Berul. Electrophysiological phenotyping in genetically engineered mice. , 2003, Physiological genomics.
[25] R. Howell,et al. Pompe disease in infants and children. , 2004, The Journal of pediatrics.
[26] L. Severijnen,et al. Morphological changes in muscle tissue of patients with infantile Pompe's disease receiving enzyme replacement therapy , 2003, Muscle & nerve.
[27] J. Smeitink,et al. Enzyme therapy for pompe disease with recombinant human alpha-glucosidase from rabbit milk. , 2001, Journal of inherited metabolic disease.
[28] D. Allen,et al. Prader-Willi syndrome: how does growth hormone affect body composition and physical function? , 2001, Journal of Pediatric Endocrinology & Metabolism (JPEM).
[29] B. Byrne,et al. Acid alpha-glucosidase deficiency (glycogenosis type II, Pompe disease). , 2002, Current molecular medicine.
[30] M. Shevell,et al. Diagnostic profile of neonatal hypotonia: an 11-year study. , 2001, Pediatric neurology.